Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
life sciences
national blog main
national top stories
san francisco top stories
4
×
biotech
boston blog main
boston top stories
clinical trials
fda
indiana blog main
indiana top stories
new york top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe top stories
gene therapy
genentech
national
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
allergy
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
What
drug
fda
4
×
therapy
4
×
approval
approved
friday
oral
patients
address
agency
aimmune
allergy
approves
aren’t
atrophy
awarded
bio
blueprint
cancer
carries
certain
daily
designed
developed
developers
drugs
evrysdi
gene
genetic
green
help
home
imminent
immunotherapy
intended
late
latest
lights
liquid
long
Language
unset
Current search:
photo
×
fda
×
" san francisco top stories "
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More